INTERCEPT PHARMACEUTICALS, INC. Quarterly Debt-to-equity in % from Q2 2013 to Q3 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Intercept Pharmaceuticals, Inc. quarterly Debt-to-equity history and growth rate from Q2 2013 to Q3 2023.
  • Intercept Pharmaceuticals, Inc. Debt-to-equity for the quarter ending September 30, 2023 was 546 %.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2023 546 +901 Sep 30, 2023
Q2 2023 527 +816 Jun 30, 2023
Q1 2023 -2.18K -1.85K -566% Mar 31, 2023
Q4 2022 -491 -109 -28.7% Dec 31, 2022
Q3 2022 -355 +40.3 +10.2% Sep 30, 2022
Q2 2022 -290 +127 +30.4% Jun 30, 2022
Q1 2022 -327 +177 +35.2% Mar 31, 2022
Q4 2021 -382 +320 +45.6% Dec 31, 2021
Q3 2021 -396 +1.08K +73.2% Sep 30, 2021
Q2 2021 -416 -4.47K -110% Jun 30, 2021
Q1 2021 -504 -1.36K -159% Mar 31, 2021
Q4 2020 -702 -1.54K -183% Dec 31, 2020
Q3 2020 -1.48K -2.34K -271% Sep 30, 2020
Q2 2020 4.05K +3.15K +349% Jun 30, 2020
Q1 2020 852 -69.5 -7.55% Mar 31, 2020
Q4 2019 842 -45.3 -5.1% Dec 31, 2019
Q3 2019 864 -24.3 -2.73% Sep 30, 2019
Q2 2019 903 +83.5 +10.2% Jun 30, 2019
Q1 2019 921 +185 +25% Mar 31, 2019
Q4 2018 887 +554 +166% Dec 31, 2018
Q3 2018 888 +679 +325% Sep 30, 2018
Q2 2018 819 +670 +451% Jun 30, 2018
Q1 2018 737 +639 +653% Mar 31, 2018
Q4 2017 333 +270 +426% Dec 31, 2017
Q3 2017 209 +174 +505% Sep 30, 2017
Q2 2017 149 +135 +966% Jun 30, 2017
Q1 2017 97.9 +88.7 +967% Mar 31, 2017
Q4 2016 63.3 +57 +918% Dec 31, 2016
Q3 2016 34.5 +28.7 +489% Sep 30, 2016
Q2 2016 14 +7.45 +114% Jun 30, 2016
Q1 2016 9.17 +1.12 +13.9% Mar 31, 2016
Q4 2015 6.22 -51.8 -89.3% Dec 31, 2015
Q3 2015 5.86 -79.5 -93.1% Sep 30, 2015
Q2 2015 6.51 -140 -95.5% Jun 30, 2015
Q1 2015 8.05 -344 -97.7% Mar 31, 2015
Q4 2014 58.1 -7.24 -11.1% Dec 31, 2014
Q3 2014 85.3 +23.3 +37.6% Sep 30, 2014
Q2 2014 146 +83.4 +133% Jun 30, 2014
Q1 2014 353 Mar 31, 2014
Q4 2013 65.3 Dec 31, 2013
Q3 2013 62 Sep 30, 2013
Q2 2013 62.7 Jun 30, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.